Zopiclone

CHEMBL135400 Phase 4 Disetujui Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

388.8 g/mol

LogP

0.5

Phase

4

This non-benzodiazepine sleep aid is prescribed for the short-term treatment of insomnia and works by enhancing GABA activity in the brain to promote sleep. It has a slightly longer duration of action than some other z-drugs, which means next-morning drowsiness and a bitter metallic taste are common side effects. Like all sleep medications, it carries a risk of dependence with prolonged use and should only be taken for short periods.

Berat Molekul

388,8000 g/mol

LogP

0,50

TPSA

91,80 Å²

Lipinski RO5

Lulus

Area Terapeutik

Pain Management Chronic Obstructive Pulmonary Disease Parkinson's Disease Migraine Schizophrenia Generalized Anxiety Disorder Insomnia Multiple Sclerosis Type 2 Diabetes Hypertension Major Depressive Disorder Chronic Pain

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1

InChI

InChI=1S/C17H17ClN6O3/c1-22-6-8-23(9-7-22)17(26)27-16-14-13(19-4-5-20-14)15(25)24(16)12-3-2-11(18)10-21-12/h2-5,10,16H,6-9H2,1H3

Molecular Formula

C17H17ClN6O3

HBD / HBA

- / 7

Ikatan yang Dapat Dirotasi

3

Atom Berat

27

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

This non-benzodiazepine sleep aid is prescribed for the short-term treatment of insomnia and works by enhancing GABA activity in the brain to promote sleep. It has a slightly longer duration of action than some other z-drugs, which means next-morning drowsiness and a bitter metallic taste are common side effects. Like all sleep medications, it carries a risk of dependence with prolonged use and should only be taken for short periods.

Yes, Zopiclone is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL135400. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 5735. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Mencari informasi yang ramah bagi pasien?

Zopiclone di PillFYI

Struktur

Data Cepat

Rumus: C17H17ClN6O3

Tautan Eksternal

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.